3 news items
Cogent Biosciences Appoints Cole Pinnow as Chief Commercial Officer
COGT
23 May 24
information at www.cogentbio.com. Follow Cogent Biosciences on social media
Cogent Biosciences Announces Positive Updated Lead-In Data from Ongoing Phase 3 PEAK Trial Evaluating Bezuclastinib in Combination with Sunitinib in Patients with Gastrointestinal Stromal Tumors (GIST) at ASCO Annual Meeting
COGT
23 May 24
on social media
Cogent Biosciences Reports First Quarter 2024 Financial Results
COGT
7 May 24
for more information at www.cogentbio.com. Follow Cogent Biosciences on social media
- Prev
- 1
- Next